Pharma companies attend HIMSS for various reasons, but many walk the show floor searching for innovative start-ups with solutions capable of delivering better outcomes and a competitive advantage in the marketplace.
In this session, Naomi Fried, a respected industry thought leader, joins with Eli Lilly and Company’s Director, Digital Health Innovation James Parshall to explore what pharma companies look for in an innovative start-up with potentially disruptive technology.
Key discussion points include:
What did Lilly learn last year from its first open Innovation Challenge?
What are good expectations for pharma and start-ups to have for each other?
What might a successful collaboration look like?
This session will get to the heart of what success looks like for all: patients, pharma, and start-up.